BTC$61,077.00-1.94%
ETH$1,630.69-1.67%
USDT$0.9986-0.01%
BNB$562.75-1.93%
USDC$0.9998+0.00%
XRP$1.07-1.25%
SOL$68.15-1.23%
TRX$0.3284-0.77%
FIGR_HELOC$1.03-0.65%
HYPE$62.70+1.21%
DOGE$0.0761-2.84%
USDS$0.99980.00%
RAIN$0.0158-1.79%
LEO$9.39-1.26%
ZEC$412.15+0.39%
XLM$0.1821-4.08%
BTC$61,077.00-1.94%
ETH$1,630.69-1.67%
USDT$0.9986-0.01%
BNB$562.75-1.93%
USDC$0.9998+0.00%
XRP$1.07-1.25%
SOL$68.15-1.23%
TRX$0.3284-0.77%
FIGR_HELOC$1.03-0.65%
HYPE$62.70+1.21%
DOGE$0.0761-2.84%
USDS$0.99980.00%
RAIN$0.0158-1.79%
LEO$9.39-1.26%
ZEC$412.15+0.39%
XLM$0.1821-4.08%
Critical Metals stock jumped in premarket trading as fresh headlines around Greenland reignited investor interest in the company’s Tanbreez rare earths project.
Fastenal posted Q4 EPS of $0.26, matching estimates, while revenue came in at $2.03B, slightly below forecasts. The company also guided for higher investment spending in…
D.R. Horton beat Wall Street estimates in Q1 fiscal 2026 as earnings rose to $2.03 per share and revenue came in at $6.9 billion, while maintaining…
3M posted a Q4 earnings and revenue beat, delivering $1.83 adjusted EPS and $6.1 billion in sales, while forecasting growth in 2026.
State Street shares slipped after the bank posted a Q4 earnings and revenue beat, but investors focused on restructuring costs and a higher-than-expected expense outlook for…
QXO stock declined over 6% in premarket trading after announcing a 31.6 million share offering priced at $23.80, below its previous close.
Regions Financial shares fell sharply in premarket trading after the bank reported fourth-quarter earnings that came in below Wall Street expectations.
ImmunityBio stock jumped after the company reported preliminary 2025 net product revenue of $113 million, up about 700% year over year.
Morgan Stanley stock rose over 4% after the bank beat Q4 estimates, posting $2.68 EPS on $17.89 billion in revenue as investment banking revenue jumped 47%.
With financials outperforming in the past year, we analyze the largest KBWB constituents to determine which bank combines earnings strength with the highest upside potential.
Boston Scientific stock slipped 3.6% in premarket trading after the company announced a $14.5 billion deal to buy Penumbra.
Ocular Therapeutix stock jumped over 18% in premarket trading after rejecting Sanofi’s $16 per share buyout offer, as investors turned bullish on the company’s late-stage pipeline.
TSMC stock jumped nearly 6% in premarket trading after the company beat Q4 earnings estimates and raised its 2026 capex plan to $52–$56 billion.